SE429165B - Kontrollosning for diagnostiska forfaranden for att pavisa emnen i urin - Google Patents

Kontrollosning for diagnostiska forfaranden for att pavisa emnen i urin

Info

Publication number: SE429165B
Authority: SE; Sweden
Prior art keywords: urine; water; soluble; control solution; pavisa
Prior art date: 1977-05-13

Application number

SE7805452A

Other languages

English (en)

Swedish (sv)

Other versions

SE7805452L (sv

Inventor

E Pfeil

H Kohl

Original Assignee

Behringwerke Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-05-13

Filing date

1978-05-11

Publication date

1983-08-15

1978-05-11 Application filed by Behringwerke Ag filed Critical Behringwerke Ag

1978-11-14 Publication of SE7805452L publication Critical patent/SE7805452L/xx

1983-08-15 Publication of SE429165B publication Critical patent/SE429165B/sv

Links

210000002700 urine Anatomy 0.000 title claims description 18
238000002405 diagnostic procedure Methods 0.000 title claims 2
POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 claims description 8
150000003839 salts Chemical class 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 7
239000000126 substance Substances 0.000 claims description 6
239000004552 water soluble powder Substances 0.000 claims description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 9
150000002576 ketones Chemical class 0.000 description 8
239000000470 constituent Substances 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000008103 glucose Substances 0.000 description 3
239000011734 sodium Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
XBIUWALDKXACEA-UHFFFAOYSA-N 3-[bis(2,4-dioxopentan-3-yl)alumanyl]pentane-2,4-dione Chemical compound CC(=O)C(C(C)=O)[Al](C(C(C)=O)C(C)=O)C(C(C)=O)C(C)=O XBIUWALDKXACEA-UHFFFAOYSA-N 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical class CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000000975 dye Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108700004676 Bence Jones Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
MZNYWPRCVDMOJG-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine dihydrochloride Chemical compound [Cl-].[Cl-].C1=CC=C2C([NH2+]CC[NH3+])=CC=CC2=C1 MZNYWPRCVDMOJG-UHFFFAOYSA-N 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
125000005595 acetylacetonate group Chemical group 0.000 description 1
239000013543 active substance Substances 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
159000000009 barium salts Chemical class 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
LVXHNCUCBXIIPE-UHFFFAOYSA-L disodium;hydrogen phosphate;hydrate Chemical compound O.[Na+].[Na+].OP([O-])([O-])=O LVXHNCUCBXIIPE-UHFFFAOYSA-L 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
-1 erythrocytes Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
150000002826 nitrites Chemical class 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
150000003142 primary aromatic amines Chemical class 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000007787 solid Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
229910052712 strontium Inorganic materials 0.000 description 1
CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
235000013619 trace mineral Nutrition 0.000 description 1
239000011573 trace mineral Substances 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
- G01N2333/765—Serum albumin, e.g. HSA
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/103332—Bilirubin or uric acid standard or control
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/104998—Glucose, ketone, nitrate standard or control
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)

SE7805452A 1977-05-13 1978-05-11 Kontrollosning for diagnostiska forfaranden for att pavisa emnen i urin SE429165B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE2721681A DE2721681B2 (de)	1977-05-13	1977-05-13	Kontroll-Lösung für diagnostische Nachweisverfahren von im Urin enthaltenen Stoffen

Publications (2)

Publication Number	Publication Date
SE7805452L SE7805452L (sv)	1978-11-14
SE429165B true SE429165B (sv)	1983-08-15

Family

ID=6008906

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7805452A SE429165B (sv)	1977-05-13	1978-05-11	Kontrollosning for diagnostiska forfaranden for att pavisa emnen i urin

Country Status (18)

Country	Link
US (1)	US4172049A (it)
JP (1)	JPS53141696A (it)
AT (1)	AT364090B (it)
AU (1)	AU514286B2 (it)
BE (1)	BE867115A (it)
CA (1)	CA1101766A (it)
CH (1)	CH647872A5 (it)
DE (1)	DE2721681B2 (it)
DK (1)	DK209978A (it)
FR (1)	FR2390733A1 (it)
GB (1)	GB1569540A (it)
IE (1)	IE46892B1 (it)
IT (1)	IT1094748B (it)
LU (1)	LU79637A1 (it)
NL (1)	NL7805122A (it)
NZ (1)	NZ187242A (it)
SE (1)	SE429165B (it)
ZA (1)	ZA782737B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4288344A (en) *	1976-11-22	1981-09-08	Andre Reiss	Stable diazonium salt generator for improved marijuana analysis
DE2855363B1 (de) *	1978-12-21	1980-05-29	Boehringer Mannheim Gmbh	Kontrollreagens fuer Teststreifen zum Nachweis von Urobilinogen im Harn
CA1150606A (en) *	1979-11-05	1983-07-26	Robert W. Trimmer	Device and method for preparation of a control solution for ketone determination
US4529704A (en) *	1979-11-05	1985-07-16	Miles Laboratories, Inc.	Device and method for preparation of a control solution for ketone determination.
CA1143634A (en) *	1980-06-02	1983-03-29	Alan E. Burkhardt	Interference-resistant test device for determining a peroxidately active substance in a test sample and method for preparing it
CA1186200A (en) *	1980-11-03	1985-04-30	John E. Sheats	Device and method for preparation of a control solution for ketone determination
EP0107029A1 (en) *	1982-09-30	1984-05-02	Miles Laboratories, Inc.	Control device and method for making same
US4649121A (en) *	1985-02-26	1987-03-10	Miles Laboratories, Inc.	Viability test device
CN102226805B (zh) *	2011-04-12	2013-07-31	桂林优利特医疗电子有限公司	一种用于尿液分析的中低浓度的阳性质控液
CN104360052B (zh) *	2014-11-05	2016-08-17	中国农业科学院农业质量标准与检测技术研究所	一种克伦特罗检测质控用动物尿液干粉及其制备方法与应用
CN106771112B (zh) *	2016-12-27	2018-08-07	迪瑞医疗科技股份有限公司	一种多项复合尿液分析质控液
CN112903873B (zh) *	2021-01-25	2023-02-17	中国农业科学院农产品加工研究所	一种经动物代谢后猪尿冻干粉中含游离态和扼合态沙丁胺醇标准物质及其制备方法
CN112903875B (zh) *	2021-01-25	2023-02-17	中国农业科学院农产品加工研究所	一种猪尿基质中扼合态和游离态共存的莱克多巴胺标准物质及其制备方法与应用
CN112903874B (zh) *	2021-01-25	2023-02-17	中国农业科学院农产品加工研究所	一种猪尿中含游离态和扼合态克伦特罗标准物质及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2283262A (en) *	1940-10-02	1942-05-19	Miles Lab	Diagnostic composition and method
US2509140A (en) *	1948-03-02	1950-05-23	Miles Lab	Test reagent composition
US2577978A (en) *	1949-02-04	1951-12-11	Miles Lab	Diagnostic composition
US2990253A (en) *	1959-05-21	1961-06-27	Miles Lab	Diagnostic composition
NL296257A (it) *	1962-08-06
US3446596A (en) *	1965-04-02	1969-05-27	Mallinckrodt Chemical Works	Analytical package and method
DE2307052C2 (de) *	1973-02-13	1974-10-31	Boehringer Mannheim Gmbh, 6800 Mannheim	Harnsäure-Standard
JPS5143796B2 (it) *	1973-11-08	1976-11-24
US3973439A (en) *	1975-04-15	1976-08-10	Westinghouse Electric Corporation	Metal acetyl acetonate composition for forming thermoparticulating coating

1977
- 1977-05-13 DE DE2721681A patent/DE2721681B2/de not_active Ceased
1978
- 1978-05-10 CH CH5080/78A patent/CH647872A5/de not_active IP Right Cessation
- 1978-05-10 LU LU79637A patent/LU79637A1/de unknown
- 1978-05-11 IT IT23304/78A patent/IT1094748B/it active
- 1978-05-11 US US05/904,993 patent/US4172049A/en not_active Expired - Lifetime
- 1978-05-11 AU AU36013/78A patent/AU514286B2/en not_active Expired
- 1978-05-11 NL NL7805122A patent/NL7805122A/xx not_active Application Discontinuation
- 1978-05-11 NZ NZ187242A patent/NZ187242A/xx unknown
- 1978-05-11 SE SE7805452A patent/SE429165B/sv unknown
- 1978-05-12 GB GB19278/78A patent/GB1569540A/en not_active Expired
- 1978-05-12 IE IE965/78A patent/IE46892B1/en unknown
- 1978-05-12 FR FR7814187A patent/FR2390733A1/fr active Granted
- 1978-05-12 DK DK209978A patent/DK209978A/da not_active Application Discontinuation
- 1978-05-12 CA CA303,178A patent/CA1101766A/en not_active Expired
- 1978-05-12 ZA ZA00782737A patent/ZA782737B/xx unknown
- 1978-05-12 AT AT0348178A patent/AT364090B/de not_active IP Right Cessation
- 1978-05-13 JP JP5617478A patent/JPS53141696A/ja active Pending
- 1978-05-16 BE BE187731A patent/BE867115A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
FR2390733A1 (fr)	1978-12-08
BE867115A (fr)	1978-11-16
GB1569540A (en)	1980-06-18
CH647872A5 (de)	1985-02-15
DK209978A (da)	1978-11-14
IT7823304A0 (it)	1978-05-11
AU3601378A (en)	1979-11-15
AU514286B2 (en)	1981-01-29
ATA348178A (de)	1981-02-15
IE780965L (en)	1978-11-13
NZ187242A (en)	1979-11-01
NL7805122A (nl)	1978-11-15
FR2390733B1 (it)	1982-07-02
IT1094748B (it)	1985-08-02
AT364090B (de)	1981-09-25
LU79637A1 (de)	1979-02-02
IE46892B1 (en)	1983-10-19
DE2721681A1 (de)	1978-11-23
DE2721681B2 (de)	1981-05-07
JPS53141696A (en)	1978-12-09
SE7805452L (sv)	1978-11-14
CA1101766A (en)	1981-05-26
ZA782737B (en)	1979-05-30
US4172049A (en)	1979-10-23

Publication	Publication Date	Title
SE429165B (sv)	1983-08-15	Kontrollosning for diagnostiska forfaranden for att pavisa emnen i urin
Beutler et al.	1955	The hemolytic effect of primaquine: VI. An in vitro test for sensitivity of erythrocytes to primaquine
US3485587A (en)	1969-12-23	Protein indicator
CH622351A5 (it)	1981-03-31
JPH03135927A (ja)	1991-06-10	低分子量有機化合物の乾燥組成物の調整方法
Chou et al.	1990	Concentration dependence of urea and thiourea transport in rat inner medullary collecting duct
US3350278A (en)	1967-10-31	Enzymatic glucose test composition and device
Quastel et al.	1931	The action of dyestuffs on enzymes: Dyestuffs and oxidations
Burnell	1968	In vivo response of muscle to changes in CO2 tension or extracellular bicarbonate
Burg et al.	1969	p-Aminohippurate uptake and exchange by separated renal tubules
Day et al.	1980	The renal response to intravenous vanadate in rats
Watkins et al.	1973	Effect of alloxan on islet tissue permeability: protection and reversal by sugars
Eadie et al.	1960	The use of DFP32 as a red cell tag with and without simultaneous tagging with chromium51 in certain animals in the presence or absence of random destruction
US4350659A (en)	1982-09-21	Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
Mouw et al.	1978	Acute effects of lead on renal electrolyte excretion and plasma renin activity
Mackenzie III et al.	1974	Heterogeneity and unusually high affinity in the interactions of adenosine 3′: 5′-monophosphate with specific binding proteins from liver and hepatoma cells
Wass et al.	1970	Transport of penicillamine across mucosa of the rat small intestine in vitro
Cockrell	1973	Energy-linked Ion Translocation in Submitochondrial Particles: III. TRANSPORT OF MONOVALENT CATIONS BY SUBMITOCHONDRIAL PARTICLES
Henry et al.	1975	Drug displacement of warfarin from human serum albumin: A fluorometric analysis
JPS63500474A (ja)	1988-02-18	採取血中のグルコース含量の低減防止法
Schmook et al.	1980	Composition of fluids from diffusion chambers implanted in the soft tissue and kidneys of rabbits
Hiranaka et al.	1972	Stability of sodium ampicillin in aqueous solutions
Pennell et al.	1949	Preparation of stabilized solutions of hemoglobin
Griffith et al.	1976	Composition of bladder urine of the coelacanth, Latimeria chalumnae
DE2302721C2 (de)	1975-01-23	Verfahren zur Bestimmung der Creatinkinase